SCHEMBL3741308

SCHEMBL3741308

COc1ccc2nccc(-n3cc4c(n3)CC[C]C4)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.47
LMNA P02545 1/20 0.39
KDM4E B2RXH2 2/20 0.38
HTR1A P08908 1/20 0.37
ADRA1D P25100 1/20 0.37
ADRA1A P35348 1/20 0.37
ADRA1B P35368 1/20 0.37
MAPK1 P28482 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
RIPK2 O43353 2/20 0.36
KDR P35968 1/20 0.36
CYP1A2 P05177 1/20 0.35
GAK O14976 1/20 0.35
COQ8A Q8NI60 1/20 0.35
NLK Q9UBE8 1/20 0.35
ROCK2 O75116 1/20 0.35
MTNR1A P48039 3/20 0.34
MTNR1B P49286 3/20 0.34
SLC22A12 Q96S37 1/20 0.34
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3073912 0.81 NCF1 (0.56) NCF1LMNAKDM4EHTR1AADRA1D
SCHEMBL3059462 0.79 NCF1 (0.48) NCF1LMNAKDM4EHTR1AADRA1D
SCHEMBL3066905 0.77 NCF1 (0.48) NCF1LMNAKDM4EHTR1AADRA1D
SCHEMBL3742840 0.77 NCF1 (0.47) NCF1LMNAKDM4EHTR1AADRA1D
SCHEMBL3072007 0.74 KDM4E (0.48) NCF1LMNAKDM4EHTR1AADRA1D
SCHEMBL24008963 0.72 NCF1 (0.45) NCF1LMNAHTR1AADRA1DADRA1A
SCHEMBL3070822 0.72 KDM4E (0.48) NCF1LMNAKDM4EHTR1AADRA1D
SCHEMBL11948039 0.72 NCF1 (0.39) NCF1KDM4EHTR1AADRA1DADRA1A
SCHEMBL3063850 0.72 NCF1 (0.41) NCF1LMNAKDM4EMAPK1NPSR1
SCHEMBL28987465 0.71 HSP90AB1 (0.41) NCF1LMNAKDM4EMAPK1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8242275-B2 Bicyclic pyrazole compounds as antibacterial agents JANSSEN PHARMACEUTICA NV (BE) 2012-08-14 US disclosed
US-8232391-B2 Bicyclic pyrazole compounds as antibacterial agents JANSSEN PHARMACEUTICA NV (BE) 2012-07-31 US disclosed
US-20100280240-A1 BICYCLIC PYRAZOLE COMPOUNDS AS ANTIBACTERIAL AGENTS ALLISON BRETT D 2010-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100280240-A1 BICYCLIC PYRAZOLE COMPOUNDS AS ANTIBACTERIAL AGENTS NOD2, BAK1, CASP3 NCF1 289/4885LMNA 2909/4885KDM4E 4629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.